Hobin Yang

518 total citations
14 papers, 357 citations indexed

About

Hobin Yang is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hobin Yang has authored 14 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hobin Yang's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers) and CAR-T cell therapy research (2 papers). Hobin Yang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers) and CAR-T cell therapy research (2 papers). Hobin Yang collaborates with scholars based in South Korea, Ethiopia and China. Hobin Yang's co-authors include Young Kee Shin, Jianbin Xu, Wei Wang, Lifen Ren‐Heidenreich, Jae‐Heon Kang, Kejing Tang, Gang Yu, Yan Qin, Juan He and Bin Shi and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Clinical & Experimental Immunology.

In The Last Decade

Hobin Yang

12 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hobin Yang South Korea	7	188	185	162	125	37	14	357
Arin Nam United States	11	150 0.8×	115 0.6×	274 1.7×	119 1.0×	72 1.9×	22	443
Ramya Kumareswaran Canada	8	187 1.0×	105 0.6×	271 1.7×	214 1.7×	29 0.8×	9	445
Ding Cheng Gao United States	3	216 1.1×	137 0.7×	189 1.2×	82 0.7×	61 1.6×	6	385
Rajeswara Rao Arasada United States	8	159 0.8×	99 0.5×	200 1.2×	73 0.6×	38 1.0×	11	328
Carlos R. Gil Del Alcazar United States	7	205 1.1×	80 0.4×	247 1.5×	109 0.9×	73 2.0×	9	440
Rania El Botty France	12	143 0.8×	73 0.4×	196 1.2×	92 0.7×	18 0.5×	23	334
Marta Popęda Poland	13	142 0.8×	79 0.4×	156 1.0×	87 0.7×	52 1.4×	32	350
Adrià Bernat‐Peguera Spain	8	163 0.9×	60 0.3×	146 0.9×	116 0.9×	46 1.2×	14	333
Dengdi Hu China	5	116 0.6×	157 0.8×	233 1.4×	175 1.4×	44 1.2×	7	379
Atsushi Fushimi Japan	13	201 1.1×	109 0.6×	329 2.0×	123 1.0×	84 2.3×	39	510

Countries citing papers authored by Hobin Yang

Since Specialization

Citations

This map shows the geographic impact of Hobin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hobin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hobin Yang more than expected).

Fields of papers citing papers by Hobin Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hobin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hobin Yang. The network helps show where Hobin Yang may publish in the future.

Co-authorship network of co-authors of Hobin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hobin Yang. A scholar is included among the top collaborators of Hobin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hobin Yang. Hobin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Choi, Jae‐Hoon, Hobin Yang, Sungyoul Hong, et al.. (2025). Abstract 6010: Evaluation of BsABN501: A novel T cell engager targeting CLDN3-positive solid tumors. Cancer Research. 85(8_Supplement_1). 6010–6010.

Choi, Jae Yong, Ho Jin Lee, Sung‐Hoon Jung, et al.. (2025). Abstract 2118: ABN501: A CLDN3-targeted monoclonal antibody with proven safety, pharmacokinetics, and synergistic anti-tumor efficacy. Cancer Research. 85(8_Supplement_1). 2118–2118.

Yang, Hobin, et al.. (2024). Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer. Translational Oncology. 51. 102204–102204. 2 indexed citations

Chelakkot, Chaithanya, Hobin Yang, & Young Kee Shin. (2022). Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse. Pharmaceuticals. 15(1). 75–75. 12 indexed citations

Lee, Mi‐Sook, Jiyoung Song, Doo‐Yi Oh, et al.. (2022). Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma. Cancer Research and Treatment. 55(2). 452–467. 3 indexed citations

Yang, Hobin, Chulhee Lee, Young‐Hwa Kim, et al.. (2022). Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer. Nuclear Medicine and Biology. 114-115. 135–142. 2 indexed citations

Yang, Hobin, et al.. (2022). Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. Frontiers in Oncology. 12. 880643–880643. 53 indexed citations

Song, Kyoung, Nirmal Rajasekaran, Chaithanya Chelakkot, et al.. (2021). Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH. Pharmaceuticals. 14(10). 1060–1060. 6 indexed citations

Cho, Soo Youn, Jinil Han, Hobin Yang, et al.. (2021). Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2–CCR2 signaling. Laboratory Investigation. 102(4). 376–390. 46 indexed citations

10.

Choi, Yoon‐La, Hyunwoo Lee, Soohyun Hwang, et al.. (2021). Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma. Cancer Research and Treatment. 54(3). 782–792. 6 indexed citations

11.

Yang, Hobin, Quoc‐Viet Le, Gayong Shim, Yu‐Kyoung Oh, & Young Kee Shin. (2020). Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles. Acta Pharmaceutica Sinica B. 10(11). 2212–2226. 27 indexed citations

12.

Yang, Hobin, Yong Jin Lee, Taeeun Kim, et al.. (2019). Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting. Biomolecules. 10(1). 51–51. 9 indexed citations

13.

Li, Sheng, Yifang Zhu, Cheng Huang, et al.. (2014). Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts. British Journal of Cancer. 110(11). 2812–2820. 179 indexed citations

14.

Yang, Hobin, et al.. (2009). The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours. Clinical & Experimental Immunology. 158(2). 174–185. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact